MXPA03006162A - Derivados de mikanolida, su preparacion y sus usos terapeuticos. - Google Patents
Derivados de mikanolida, su preparacion y sus usos terapeuticos.Info
- Publication number
- MXPA03006162A MXPA03006162A MXPA03006162A MXPA03006162A MXPA03006162A MX PA03006162 A MXPA03006162 A MX PA03006162A MX PA03006162 A MXPA03006162 A MX PA03006162A MX PA03006162 A MXPA03006162 A MX PA03006162A MX PA03006162 A MXPA03006162 A MX PA03006162A
- Authority
- MX
- Mexico
- Prior art keywords
- preparation
- therapeutic uses
- mikanolide
- derivatives
- mikanolide derivatives
- Prior art date
Links
- JRZGAAFGODYEEA-ATNXOXLHSA-N Mikanolide Chemical class C([C@]1([C@H]([C@@H]2O[C@@H]22)O1)C)[C@@H]1OC(=O)C(=C)[C@H]1[C@@H]1OC(=O)C2=C1 JRZGAAFGODYEEA-ATNXOXLHSA-N 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
- C07D493/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0100397A FR2819513B1 (fr) | 2001-01-12 | 2001-01-12 | Nouveaux derives du mikanolide, leur preparation et leurs applications therapeutiques |
| FR0114688 | 2001-11-14 | ||
| PCT/FR2002/000092 WO2002055523A1 (fr) | 2001-01-12 | 2002-01-11 | Derives du mikanolide, leur preparation et leurs applications therapeutiques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA03006162A true MXPA03006162A (es) | 2003-09-16 |
Family
ID=26212826
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA03006162A MXPA03006162A (es) | 2001-01-12 | 2002-01-11 | Derivados de mikanolida, su preparacion y sus usos terapeuticos. |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US6887869B2 (es) |
| EP (1) | EP1353926B1 (es) |
| JP (1) | JP4418627B2 (es) |
| KR (1) | KR100859227B1 (es) |
| CN (1) | CN1234711C (es) |
| AR (1) | AR035681A1 (es) |
| AT (1) | ATE319716T1 (es) |
| AU (1) | AU2002229870B2 (es) |
| BR (1) | BR0206311A (es) |
| CA (1) | CA2433981A1 (es) |
| CZ (1) | CZ20032167A3 (es) |
| DE (1) | DE60209698T2 (es) |
| ES (1) | ES2260417T3 (es) |
| MX (1) | MXPA03006162A (es) |
| MY (1) | MY130454A (es) |
| NZ (1) | NZ526690A (es) |
| PL (1) | PL365342A1 (es) |
| RU (1) | RU2278121C2 (es) |
| TW (1) | TWI293302B (es) |
| WO (1) | WO2002055523A1 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4767848B2 (ja) * | 2003-07-11 | 2011-09-07 | ユニヴァーシティ オブ ケンタッキー リサーチ ファウンデーション | パルテノライド誘導体を抗白血病薬及び細胞毒性薬として使用する方法 |
| US7678904B2 (en) | 2003-07-11 | 2010-03-16 | University Of Kentucky | Use of parthenolide derivatives as antileukemic and cytotoxic agents |
| CN103004761B (zh) * | 2012-12-27 | 2013-12-04 | 中山火炬职业技术学院 | 一种薇甘菊正丁醇提取物及其制备方法和用途 |
| CN106719727A (zh) * | 2016-12-13 | 2017-05-31 | 安徽东健化工科技有限公司 | 一种除虫剂 |
| CN111484503B (zh) * | 2020-01-10 | 2022-05-27 | 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) | 一种薇甘菊内酯衍生物及其制备方法和应用 |
| CN115918668B (zh) * | 2022-12-13 | 2024-03-22 | 西南林业大学 | 倍半萜内酯作抗烟草花叶病毒药物的应用及其制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2696460B1 (fr) * | 1992-10-05 | 1994-11-25 | Rhone Poulenc Rorer Sa | Procédé de préparation de dérivés du taxane. |
| US5380751A (en) * | 1992-12-04 | 1995-01-10 | Bristol-Myers Squibb Company | 6,7-modified paclitaxels |
| FR2801792B1 (fr) * | 1999-12-01 | 2003-04-18 | Sod Conseils Rech Applic | Un nouveau medicament, le dihydromikanolide, son obtention par extraction de la plante mikania micrantha et son utilisation comme agent anti-proliferatif |
-
2001
- 2001-12-25 TW TW090132164A patent/TWI293302B/zh active
- 2001-12-31 MY MYPI20015945A patent/MY130454A/en unknown
-
2002
- 2002-01-11 AR ARP020100095A patent/AR035681A1/es unknown
- 2002-01-11 ES ES02710969T patent/ES2260417T3/es not_active Expired - Lifetime
- 2002-01-11 AT AT02710969T patent/ATE319716T1/de not_active IP Right Cessation
- 2002-01-11 RU RU2003124760/04A patent/RU2278121C2/ru not_active IP Right Cessation
- 2002-01-11 PL PL02365342A patent/PL365342A1/xx not_active Application Discontinuation
- 2002-01-11 NZ NZ526690A patent/NZ526690A/en unknown
- 2002-01-11 DE DE60209698T patent/DE60209698T2/de not_active Expired - Lifetime
- 2002-01-11 CA CA002433981A patent/CA2433981A1/fr not_active Abandoned
- 2002-01-11 MX MXPA03006162A patent/MXPA03006162A/es active IP Right Grant
- 2002-01-11 BR BR0206311-5A patent/BR0206311A/pt not_active IP Right Cessation
- 2002-01-11 CN CNB02803614XA patent/CN1234711C/zh not_active Expired - Fee Related
- 2002-01-11 EP EP02710969A patent/EP1353926B1/fr not_active Expired - Lifetime
- 2002-01-11 KR KR1020037009279A patent/KR100859227B1/ko not_active Expired - Fee Related
- 2002-01-11 US US10/250,383 patent/US6887869B2/en not_active Expired - Fee Related
- 2002-01-11 WO PCT/FR2002/000092 patent/WO2002055523A1/fr not_active Ceased
- 2002-01-11 CZ CZ20032167A patent/CZ20032167A3/cs unknown
- 2002-01-11 JP JP2002556192A patent/JP4418627B2/ja not_active Expired - Fee Related
- 2002-01-11 AU AU2002229870A patent/AU2002229870B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| NZ526690A (en) | 2005-02-25 |
| KR20030066806A (ko) | 2003-08-09 |
| ES2260417T3 (es) | 2006-11-01 |
| KR100859227B1 (ko) | 2008-09-18 |
| JP2004520353A (ja) | 2004-07-08 |
| RU2003124760A (ru) | 2005-01-10 |
| US6887869B2 (en) | 2005-05-03 |
| TWI293302B (en) | 2008-02-11 |
| BR0206311A (pt) | 2004-02-17 |
| DE60209698T2 (de) | 2006-11-16 |
| CA2433981A1 (fr) | 2002-07-18 |
| EP1353926B1 (fr) | 2006-03-08 |
| DE60209698D1 (de) | 2006-05-04 |
| AR035681A1 (es) | 2004-06-23 |
| CZ20032167A3 (en) | 2004-05-12 |
| ATE319716T1 (de) | 2006-03-15 |
| WO2002055523A1 (fr) | 2002-07-18 |
| CN1484646A (zh) | 2004-03-24 |
| AU2002229870B2 (en) | 2006-07-13 |
| MY130454A (en) | 2007-06-29 |
| JP4418627B2 (ja) | 2010-02-17 |
| PL365342A1 (en) | 2004-12-27 |
| RU2278121C2 (ru) | 2006-06-20 |
| EP1353926A1 (fr) | 2003-10-22 |
| US20040122084A1 (en) | 2004-06-24 |
| CN1234711C (zh) | 2006-01-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20040027A2 (en) | 1-phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use | |
| AU2002340999A1 (en) | Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use | |
| ZA200407868B (en) | 17alpha-Alkyl-17beta-oxy-estratrienes, uses thereof and pharmaceutical preparations. | |
| MXPA03000753A (es) | Derivados de benzimidazola, su preparacion y su aplicacion terapeutica. | |
| HUP0401335A3 (en) | Herbicidal pyridylpropynyloxyphenyl derivatives, preparation and use thereof | |
| IL159507A0 (en) | Substituted dihydro 3-halo-1h pyrazole-5-carboxylates, their preparation and use | |
| AU2002359126A8 (en) | Benzodiazepine derivatives, preparation thereof and use thereof | |
| AU2002359123A8 (en) | Benzodiazepine derivatives, preparation thereof and use thereof | |
| TWI319400B (en) | Piperazinylacylpiperidine derivatives, their preparation and their therapeutic application | |
| TWI318974B (en) | Acylaminothiazole derivatives, their preparation and their therapeutic use | |
| AU2001264042A1 (en) | 1,4-diazabicyclo(3.2.2)nonane-phenylisoxazole derivatives, preparation and therapeutic use thereof | |
| ZA200003706B (en) | Cyclobutene derivatives, their preparation and their therapeutic uses. | |
| AU2001264044A1 (en) | 1,4-diazabicyclo(3.2.2)nonabenzoxazole, -benzothiazole and benzimidazole derivatives, preparation and therapeutic use thereof | |
| ZA200001746B (en) | 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use. | |
| PT1525193E (pt) | Derivados do acilaminotiazole e sua utilização como inibidores de beta amilóide | |
| TWI320413B (en) | 1,4-diazabicyclo [ 3.2.2 ] nonanecarboxamide derivatives, preparation thereof and therapeutic use thereof | |
| HUP0600238A3 (en) | Benzothiazole- and benzoxazole-4,7-dione derivatives and their use | |
| MXPA03006249A (es) | Derivados de 2-arilimino-2,3-dihidrotiazoles, sus procesos de preparacion y su uso terapeutico. | |
| MXPA03006162A (es) | Derivados de mikanolida, su preparacion y sus usos terapeuticos. | |
| MXPA03008393A (es) | Derivados de guanidina biciclicos y usos terapeuticos de los mismos. | |
| AU2002229870A1 (en) | Mikanolide derivatives, their preparation and therapeutic uses | |
| PL375309A1 (en) | Acyloxypyrrolidine derivatives, preparation and therapeutic use thereof | |
| PL362573A1 (en) | Imidazolidine derivatives, their preparation, and their use as antinflamatory agent. | |
| IL161859A0 (en) | 3-Heteroaryl-3.5-dihydro-4-oxo-4H-pyridazinoÄ4.5-BÜindole-1-carboxamide derivatives, their preparation and therapeutic use | |
| AU2001284084A1 (en) | Polyfluoroalkyltriazole derivatives, preparation and therapeutic use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration | ||
| HC | Change of company name or juridical status |